Top Markets
Coin of the day
Mendus AB (publ) Mendus AB (publ)

Mendus AB (publ)

IMMU
Rangering i aksjer #25837
Mendus AB (publ), a biopharmaceutical entity formerly known as Immunicum AB... Mendus AB (publ), a biopharmaceutical entity formerly known as Immunicum AB (publ) until its name change in June 2022, specializes in developing immunotherapies and vaccines designed to prevent cancer recurrence. Its primary investigational compound, ilixadencel, is currently progressing through a Phase II MERECA clinical study for kidney cancer, alongside Phase I/II trials targeting liver cancer and gastrointestinal stromal tumors. Additionally, the company is advancing DCP-001, which is undergoing Phase II ADVANCE-II clinical research for acute myeloid leukemia and Phase I/II ALISON trials for ovarian cancers. Mendus maintains research partnerships with PCI Biotech Holding ASA to explore novel cancer vaccination approaches and with the Icahn School of Medicine at Mount Sinai. Founded in 2002, Mendus AB is headquartered in Stockholm, Sweden.
Aksjekurs
$0.74834668
Sist synkronisert: 2026-08-20
Markedsverdi
$45.86M
Endring (1 dag)
-0.15%
Endring (1 år)
-2.71%
Land
SE
Handel Mendus AB (publ) (IMMU)

Kategori

Aksjeprishistorikk for Mendus AB (publ) (IMMU)
Høyeste sluttskurs: $0.75 den 2026-08-01

Laveste sluttskurs: $1.01 den 2013-04-01
Aksjeprishistorikk for Mendus AB (publ) fra 2013 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 14.30%
2025 -29.72%
2024 -32.55%
2023 -76.95%
2022 -39.21%
2021 -55.05%
2020 -17.38%
2019 29.23%
2018 -11.66%
2017 -59.00%
2016 -42.62%
2015 63.38%
2014 -42.62%
2013 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$539.14 35.65%
US
$1.04K 56.21%
NL
$119.69 -17.56%
AU
$761.87 8.65%
CH
$130.43 397.46%
US